World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02145975
Date of registration: 18/05/2014
Prospective Registration: No
Primary sponsor: Universidad de Antioquia
Public title: Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine
Scientific title: Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine: a Randomized Parallel-group, Double-blind Clinical Trial
Date of first enrolment: January 2014
Target sample size: 60
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02145975
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
Colombia
Contacts
Name:     Adriana Cadavid, MD
Address: 
Telephone:
Email:
Affiliation:  Antioquia University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients physical status I and IV, 18-65 years of age

- Patients scheduled for surgery under general or regional anesthesia and fasting as
defined in the fasting guidelines.

- Patients whose accept and sign the informed consent of study.

Exclusion Criteria:

- Patients with severe respiratory depression given by a monitoring state indicating
hypoxemia (oxyhemoglobin saturation below 90 %).

Patients with immediate postoperative hemodynamic instability given by bradycardia ,
hypotension or hypoperfusion states observed by clinical paleness, active bleeding,
altered sensorium, and altered alertness not explained by effects of anesthetics .

Neurological disorders such as metabolic basis psychiatric disorders, mental retardation,
congenital neurodegenerative conditions, hypoxic or ischemic related to aging that do not
allow adequate evaluation of the analog scale pain assessment.

Patients with a history of tolerance to opioids for chronic use, which is defined to a
period of 2 weeks.

Patients who have undergone epidural analgesia protocols, neuraxial and peripheral nerve
blocks.

Patients with any alteration in neurological status. History of psychiatric disorders.
Patient with known hypersensitivity or allergic reactions to opioids. Women who are
pregnant or suspected to be.



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Postoperative Pain
Intervention(s)
Drug: Fentanyl
Drug: Morphine
Primary Outcome(s)
Time in minutes of titration of fentanyl and morphine in reducing severe postoperative pain to mild pain [Time Frame: The outcome will be measured from the patient presents severe pain at the PACU until the time that presents mild pain and he does not need more rescue bolus assessed up to 4 hours]
Secondary Outcome(s)
Cumulative dosis [Time Frame: The outcome will be measured from the patient experiences severe pain at the PACU and is given the first bolus rescue analgesic until is given last bolus rescue analgesic, assessed up to 4 hours]
Stay time of patients in the postanesthetic recovery unit in hours. [Time Frame: The outcomes will be measured from the patient arrives at the PACU until he is discharged or transferred to the hospital room assessed up to 4 hours.]
Satisfaction with the analgesic management [Time Frame: This outcome will be measured in the first hour at the PACU and postoperative 24 hours]
Saturation of oxygen and arterial pressure [Time Frame: The outcomes will be measured from the patient arrives at the PACU until he is discharged or transferred to the hospital room, assessed up to 4 hours.]
Secondary ID(s)
UDEAFEN001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history